---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-25-000012"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T05:18:09.253087+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Merit Medical Q4 revenue $355M (+9.4%); Non-GAAP EPS $0.93 (+25.8%); FY 2025 guidance issued

## Summary
- Q4 2024 revenue $355.2M, up 9.4% YoY; constant currency revenue up 10.1%; organic constant currency up 6.1%.
- Non-GAAP EPS $0.93, up 25.8%; GAAP EPS $0.46, down 2.6%. Non-GAAP operating margin improved to 19.6% from 16.6%.
- Full year 2024 revenue $1.357B (+7.9%); Non-GAAP EPS $3.46 (+21.3%); free cash flow $185.7M (+67.5%).
- Completed acquisition of Cook Medical lead management portfolio; FDA PMA received for Wrapsody dialysis device.
- FY 2025 guidance: revenue $1.47-1.49B (8-10% growth); Non-GAAP EPS $3.58-$3.70 (4-7% growth).

## SEC filing metadata
- accession: 0000856982-25-000012
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698225000012/0000856982-25-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698225000012/mmsi-20250225x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-25-000012
- JSON: https://secwatch.observer/filing/0000856982-25-000012.json
- Plain text: https://secwatch.observer/filing/0000856982-25-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.